Silencing 'junk' gene THOR could slow tumour growth
Scientists in the USA have found a novel non-coding gene that alters proliferation in cancer cells to help tumour development...
BioNews
163 articles
FDA okays test for many cancer-causing genes
The US Food and Drug Administration has approved a test which can detect cancer-causing mutations in 324 genes...
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
Genetic 'sensor' spots and kill cells with key cancer gene
A team of scientists in Germany has developed a 'sensor' that detects mutations in the key tumour suppressor gene p53 and then kills potentially cancerous cells...
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
Stem cell therapy shows promise in patients with sight loss
Preliminary results from two early stage clinical trials suggest that embryonic stem cells could be used to treat patients with dry age-related macular degeneration...
AI test could be first screening tool for ovarian cancer
Machine learning has been used to develop a promising screening test for ovarian cancer, a team of US-based researchers has said...
Twenty-seven genes that suppress cancer discovered
Scientists have found 27 new tumour suppressor genes...
Number of mutations needed to cause cancer calculated
Between one and 10 mutations are required for a healthy cell to turn cancerous...
Child brain cancer redefined as 10 different diseases
Deadly childhood brain tumours are highly diverse and can be divided into 10 different subtypes, according to new research...
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CRISPR used to uncover new drug targets for cancer
New potential drug targets have been identified for cancers associated with KRAS gene mutations, which are thought to drive around 20-30 percent of all human cancers...
Cancer mutations explored using organoids and CRISPR
Organoids and CRISPR/Cas9 have been combined in a novel method to study genetic mutations occurring in cancer...